Niagen Bioscience Inc (NAGE) Stock

Niagen Bioscience Inc (NAGE) is a Healthcare stock trading at $3.49 (as of 2026-06-18), with a market capitalization of $307.43M and a trailing P/E of 18.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Niagen Bioscience Inc is a bioscience company focused on healthy aging. The company conducts research related to nicotinamide adenine dinucleotide (NAD).

Valuation — source: SEC EDGAR (first-party)
Price$3.49
Market Cap$307.43M
P/E Ratio18.4
EV / EBITDA17.6
Price / Book3.73
Price / Sales2.36
DCF Value (model)$3.68
DCF Upside vs Price5.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$129.42M
Net Margin13.4%
Return on Equity22.6%
Current Ratio4.61
Revenue Growth (YoY)3.3%
EPS Growth (YoY)14.3%
Financial Health — source: SEC EDGAR
Altman Z-Score6.04 (safe)
Valuation vs Sector & Industry
Stock P/E18.4
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-12.3%
vs Industry6.5%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderVANGUARD GROUP INC ($20.90M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEORobert N. Fried
Employees104
CountryUS
IPO Date2015-06-24

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

  • Seneca Foods Corporation (SENEB)
  • Seneca Foods Corporation (SENEA)
  • Mama's Creations, Inc. (MAMA)
  • MGP Ingredients, Inc. (MGPI)
  • Nu Skin Enterprises, Inc. (NUS)
  • SNDL Inc. (SNDL)
  • Johnson Outdoors Inc. (JOUT)
  • Helen of Troy Limited (HELE)
NAGE earnings history · NAGE institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.